Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) (2015)
- Authors:
- Autor USP: ODONE FILHO, VICENTE - FM
- Unidade: FM
- Subjects: NEOPLASIAS CEREBRAIS (TERAPIA); ADOLESCENTES; CRIANÇAS; RADIOTERAPIA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2015
- Source:
- Título: Journal of Clinical Oncology
- ISSN: 0732-183X
- Volume/Número/Paginação/Ano: v. 33, n. 15S , abstr. 10061, 2015
- Conference titles: ASCO Annual Meeting
-
ABNT
EPELMAN, Sidnei et al. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10061?sid=ec5521be-1bcd-4729-88fd-8af50b936997. Acesso em: 23 fev. 2026. , 2015 -
APA
Epelman, S., Odone, V., Gorender, E., Medeiros, R. S. S., & Martins, L. (2015). Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10061?sid=ec5521be-1bcd-4729-88fd-8af50b936997 -
NLM
Epelman S, Odone V, Gorender E, Medeiros RSS, Martins L. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2026 fev. 23 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10061?sid=ec5521be-1bcd-4729-88fd-8af50b936997 -
Vancouver
Epelman S, Odone V, Gorender E, Medeiros RSS, Martins L. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2026 fev. 23 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10061?sid=ec5521be-1bcd-4729-88fd-8af50b936997 - Gene expression profile analysis between CD10 positive standard risk all with good and poor response to induction theraphy:: identification of potencial target genes
- Aspectos clllínicos, terapêuticos e variáveis de prognostico em crianças maiores de um ano portadoras de neuroblastoma não disseminado
- Desnutrição no câncer infantil
- Sarcomas
- Tumores cerebrais
- Leucemias agudas da infância
- Tumores sólidos na infância
- Avaliação da sobrevida de pacientes com leucemia linfóide aguda na infância tratadas de acordo com diferentes protocolos em uma instituição
- Atypical presentation of a germline APC mutation in a child with supratentorial primitive neuroectodermal tumor [Carta]
- Uso de r-Hu-Eritropoetina *(EPO) em crianças com leucemia linfoblástica aguda (LLA) de alto risco submetidas à quimioterapia agressiva
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
